Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
3,086
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Identifying the molecular targets and mechanisms of xuebijing injection for the treatment of COVID-19 via network pharmacology and molecular docking

Zhao Tianyua Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun City, Jilin Province, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6386-0468View further author information
ORCID Icon &
Guan Liyingb Department of Pharmacy, China-Japan Union Hospital, Jilin University; Changchun City, Jilin Province, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3419-9842View further author information
ORCID Icon
Pages 2274-2287 | Received 16 Mar 2021, Accepted 13 May 2021, Published online: 02 Jun 2021

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Tianyue Wang, Xinyu Jiang, Yanmin Ruan, Jun Zhuang & Yuanjun Yin. (2022) Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction. Bioengineered 13:5, pages 13767-13783.
Read now
Ameny Farhat, Hajer Ben Hlima, Bassem Khemakhem, Youssef Ben Halima, Philippe Michaud, Slim Abdelkafi & Imen Fendri. (2022) Apigenin analogues as SARS-CoV-2 main protease inhibitors: In-silico screening approach. Bioengineered 13:2, pages 3350-3361.
Read now
Haitao Tu, Duanhua Ma, Yuanyuan Luo, Shuifu Tang, Ying Li, Gangyi Chen, Liangliang Wang, Zhengkun Hou, Chuangpeng Shen, Huan Lu, Xun Zhuang & Liangyou Zhang. (2021) Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway. Bioengineered 12:1, pages 6538-6558.
Read now

Articles from other publishers (14)

Tian Wang, Linxi Lv, Hui Feng & Wei Gu. (2024) Unlocking the Potential: Quercetin and Its Natural Derivatives as Promising Therapeutics for Sepsis. Biomedicines 12:2, pages 444.
Crossref
Ning Li, Ya Gao, Lingfei Liu, Qin Hu, Lixia Xiao & Tianzhu Guan. (2024) Exploring the pharmacological mechanisms of star anise against COVID‐19 using network pharmacology and molecular docking. Food Safety and Health 2:1, pages 145-157.
Crossref
Shenghao Li, Liyuan Hao, Jiali Deng, Junli Zhang & Xiaoyu Hu. (2023) Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease‐related liver cancer by AKT . Chemical Biology & Drug Design 102:4, pages 828-842.
Crossref
Yao Chen, Jianbo Guo, Wei Peng, Xiangyin Xiang, Yifan Wang, Yi Luo, Yibin Feng, Vivian Taam Wong & Haiyong Chen. (2023) Treatment of COVID-19-Induced Systematic Inflammatory Response and Multiple Organ Failure Using Xuebijing. Integrative Medicine in Nephrology and Andrology 10:3.
Crossref
Mengchi Chen, Wenbo Shu, Jingfeng Zhang, Hongyuan Huang & Jianghua Liu. (2023) Mechanisms and clinical application of Xuebijing injection, a traditional Chinese herbal medicine–a systematic review. Advances in Traditional Medicine.
Crossref
Changya Liu, Xinxin Wu, Hongqiang Yang, Xiangru Xu, Caiyu Chen, Linguangjin Wu, Wen Zhang, Haimei Shi, Yuerong Fei, Yuting Sun, Hongze Wu, Shuang Zhou & Bangjiang Fang. (2023) A retrospective study of Reyanning mixture in elderly patients infected with SARS-CoV-2 Omicron variant. Frontiers in Pharmacology 14.
Crossref
Cheng Zhang, Guoming Chen, Guoyi Tang, Xiaoyu Xu, Zixin Feng, Yuanjun Lu, Yau-Tuen Chan, Junyu Wu, Yuanyuan Chen, Lin Xu, Qing Ren, Hongchao Yuan, Dong-Hua Yang, Zhe-Sheng Chen, Ning Wang & Yibin Feng. (2023) Multi-component Chinese medicine formulas for drug discovery: State of the art and future perspectives. Acta Materia Medica 2:1.
Crossref
Xiang-ru Xu, Wen Zhang, Xin-xin Wu, Hong-qiang Yang, Yu-ting Sun, Yu-ting Pu, Bei Wang, Wei Peng, Li-hua Sun, Quan Guo, Shuang Zhou & Bang-jiang Fang. (2022) Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking. Journal of Integrative Medicine 20:6, pages 561-574.
Crossref
Jie Gao, Guangxu Xiao, Guanwei Fan, Han Zhang, Yan Zhu & Ming Lü. (2022) Clinical and pharmacological research progress of “three medicines and three formulae” for COVID-19 treatment. Chinese Science Bulletin 67:27, pages 3296-3310.
Crossref
Rui Gao, Xiaobo Zhang, Zhen Zhou, Jiayi Sun, Xuehua Tang, Jialiang Li, Xin Zhou & Tao Shen. (2022) Pharmacological Mechanism of Ganlu Powder in the Treatment of NASH Based on Network Pharmacology and Molecular Docking. Disease Markers 2022, pages 1-12.
Crossref
Taner DAŞ & Aytül BUĞRA. (2022) How did research article publications on the COVID-19 pandemic progress in the Q1 ranked SCImage index journals in 2020?. Journal of Health Sciences and Medicine 5:2, pages 368-373.
Crossref
Ke-Yao Xia, Zeyuan Zhao, Taif Shah, Jing-Yi Wang & Zulqarnain Baloch. (2022) Composition, Clinical Efficiency, and Mechanism of NHC-Approved “Three Chinese Medicines and Three Chinese Recipes” for COVID-19 Treatment. Frontiers in Pharmacology 12.
Crossref
Chen Cheng & Xuan Yu. (2021) Research Progress in Chinese Herbal Medicines for Treatment of Sepsis: Pharmacological Action, Phytochemistry, and Pharmacokinetics. International Journal of Molecular Sciences 22:20, pages 11078.
Crossref
Esra GÜZEL TANOĞLU & M.fevzi ESEN. (2021) Evaluation of studies on molecular biology and genetics related to COVID-19 with data mining. Journal of Health Sciences and Medicine 4:6, pages 960-966.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.